In addition, LYN overexpression has been reported in several cancers, such as chronic myelogenous leukemia [15], colorectal cancer [16], breast cancer [17], prostate cancer [18], oral cancer [19], renal cancer [20] and gastric cancer [21]. The gene discussed is LYN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.